Business

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

CNBC · September 21, 2026 at 12:59 PM

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

This outlet doesn’t distribute a summary in its feed — read the full article at the source.

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

More from CNBC

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Cramer’s week ahead: Earnings kick off as banks and chipmakers face big tests

French yields are near levels not seen since 2002. Why that could give U.S. Treasurys a boost

Junk bonds are 'flashing yellow.' Watch these warning signs

More in Business

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

An NYU professor says OpenAI's mass release of math papers wiped out early-career researchers' projects

‘I have no children’: My aunt gave me $50,000 for a down payment. Now she wants me to leave my home to her two children.

‘I feel like a loser’: I check my ETFs every day. They’re up one minute, down the next. Should I be worried?

Elon Musk is beefing with telecom billionaire Mukesh Ambani as Starlink’s launch in India stalls. Here's why.

Philadelphia police say Anthropic AI submitted a "false homicide tip"